Trademark Overview
On Wednesday, January 15, 2025, a trademark application was filed for ONHIRA with the United States Patent and Trademark Office. The USPTO has given the ONHIRA trademark a serial number of 98964641. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, January 15, 2025. This trademark is owned by TEVA PHARMACEUTICALS USA, Inc.. The ONHIRA trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of autoimmune, cancer, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, infectious, inflammatory, menopausal, neurological, pain, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for use in hematology